Aziz T - Search Results

1

Validating parameters of a luciferase reporter gene assay to measure neutralizing antibodies to IFNbeta in multiple sclerosis patients.

Lam R, Farrell R, Aziz T, Gibbs E, Giovannoni G, Grossberg S, Oger J. Lam R, et al. Among authors: aziz t. J Immunol Methods. 2008 Jul 31;336(2):113-8. doi: 10.1016/j.jim.2008.03.014. Epub 2008 May 1. J Immunol Methods. 2008. PMID: 18511063

2

During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4.

Basile E, Gibbs E, Aziz T, Oger J. Basile E, et al. Among authors: aziz t. J Neuroimmunol. 2006 Aug;177(1-2):161-6. doi: 10.1016/j.jneuroim.2006.04.024. Epub 2006 Jun 12. J Neuroimmunol. 2006. PMID: 16765453 Clinical Trial.

3

Chronic progressive multiple sclerosis: changes in phenotype and function of T helper subsets.

O'Gorman MR, Aziz T, Oger J. O'Gorman MR, et al. Among authors: aziz t. J Neuroimmunol. 1989 Sep;24(1-2):163-8. doi: 10.1016/0165-5728(89)90110-0. J Neuroimmunol. 1989. PMID: 2530247

4

Serum proteomics in multiple sclerosis disease progression.

Tremlett H, Dai DL, Hollander Z, Kapanen A, Aziz T, Wilson-McManus JE, Tebbutt SJ, Borchers CH, Oger J, Cohen Freue GV. Tremlett H, et al. Among authors: aziz t. J Proteomics. 2015 Apr 6;118:2-11. doi: 10.1016/j.jprot.2015.02.018. Epub 2015 Mar 6. J Proteomics. 2015. PMID: 25753122

5

In myasthenia gravis cells from atrophic thymus secrete acetylcholine receptor antibodies.

Katzberg HD, Aziz T, Oger J. Katzberg HD, et al. Among authors: aziz t. Neurology. 2001 Feb 27;56(4):572-3. doi: 10.1212/wnl.56.4.572. Neurology. 2001. PMID: 11222815 No abstract available.

6

In myasthenia gravis, clinical and immunological improvement post-thymectomy segregate with results of in vitro antibody secretion by immunocytes.

Katzberg HD, Aziz T, Oger J. Katzberg HD, et al. Among authors: aziz t. J Neurol Sci. 2002 Oct 15;202(1-2):77-83. doi: 10.1016/s0022-510x(02)00226-5. J Neurol Sci. 2002. PMID: 12220697

7

Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada.

Pakzad Z, Aziz T, Oger J. Pakzad Z, et al. Among authors: aziz t. Neurology. 2011 Apr 26;76(17):1526-8. doi: 10.1212/WNL.0b013e318217e735. Neurology. 2011. PMID: 21519005 No abstract available.

8

A sensitive radioimmunoprecipitation assay for assessing the clinical relevance of antibodies to IFN beta.

Lawrence N, Oger J, Aziz T, Palace J, Vincent A. Lawrence N, et al. Among authors: aziz t. J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1236-9. doi: 10.1136/jnnp.74.9.1236. J Neurol Neurosurg Psychiatry. 2003. PMID: 12933925 Free PMC article. Clinical Trial.

9

Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?

Bar-Or A, Oger J, Gibbs E, Niino M, Aziz T, Renoux C, Alatab S, Shi FD, Campagnolo D, Jalili F, Rhodes S, Yamashita T, Fan B, Freedman MS, Panitch H, Arnold DL, Vollmer T. Bar-Or A, et al. Among authors: aziz t. Mult Scler. 2009 Aug;15(8):959-64. doi: 10.1177/1352458509106230. Mult Scler. 2009. PMID: 19667022 Clinical Trial.

10

Natural killer (NK) cells in chronic progressive multiple sclerosis patients treated with lymphoblastoid interferon.

Kastrukoff LF, Morgan NG, Aziz TM, Zecchini D, Berkowitz J, Paty DW. Kastrukoff LF, et al. Among authors: aziz tm. J Neuroimmunol. 1988 Nov;20(1):15-23. doi: 10.1016/0165-5728(88)90109-9. J Neuroimmunol. 1988. PMID: 3183034 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,321 results

Search Page

Filters